Development of COVID-19 Vaccine, Tests Advancing in Montana

Inimmune Corporation is joining in on efforts to develop a COVID-19 vaccine with a nasal spray that could offer protection against coronavirus.  The research efforts are in collaboration with the University of Montana’s Center for Translational Medicine and Rocky...

Science Behind the Silent Killer

The science behind the silent killer.  Here is how Inimmune is developing vaccines to help solve the opioid epidemic. Read full article: Science and the Silent Killer

Vaccine targeting opioid addiction with Dr. Jay Evans

The University of Montana is a recipient of a $3.3 million dollar contract from the National Institutes of Health to develop a vaccine to treat opioid addiction.  Inimmune Corporation will be a collaborator in developing this project.  Watch the interview to...

The Future of Food Allergies – Developing New Treatments

Inimmune is developing vaccines to treat food allergies.  Read about the future prospects of treatments for food allergies here.